Product

LNF1901 Monoclonal Antibody

Aliases

LNF1901 Monoclonal Antibody Injection

1 clinical trial

1 indication

Indication

Advanced Malignant Tumors

Clinical trial

Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Characteristics and Initial Efficacy of LNF1901 in Advanced Malignant Tumors

Status: Not yet recruiting, Estimated PCD: 2025-02-01